Nava Whiteford

As an expert in DNA sequencing technology, Nava has engaged in the development of numerous novel sequencing platforms. This includes novel algorithmic approaches to the analysis of sequencing-by-synthesis (Illumina and others), protein-nanopores (at Oxford Nanopore), solid-state nanopore (as CTO of Quantum Biosystems), and other (XGenomes) datasets.

At Kern, Nava is able to apply his deep understanding of various methods of how to “read” DNA to the development of Kern's novel enzymatic DNA synthesis approach— helping us scale our DNA “write” platform. Furthermore, he is assisting us with computational aspects of our platform including our encoding/decoding process, protein engineering, and the development of our hardware platform.